Skip to main content

Table 2 Outcomes for all patients

From: A long-term follow-up study investigating health-related quality of life and resource use in survivors of severe sepsis: comparison of recombinant human activated protein C with standard care

Outcome

APC (n = 35)

Standard care (n = 63)

Total (n = 98)

P values

ICU LOS (median [IQR])

14.7 (10.0 to 23.3)

15.2 (9.4 to 29.4)

14.9 (9.6 to 25.5)

0.65

Hospital LOS (median [IQR])

36.0 (21.0 to 58.0)

48.0 (31.0 to 78.4)

42.0 (29.0 to 75.0)

0.05

ICU outcomes (n [%])

   

0.71

   Transfer to another acute care facility

1 (2.9%)

3 (4.8%)

4 (4.1%)

 

   Ward

34 (97.1%)

58 (92.1%)

92 (93.9%)

 

   Home

0 (0.0%)

1 (1.6%)

1 (1.0%)

 

   Expired

0 (0.0%)

1 (1.6%)

1 (1.0%)

 

Hospital outcomes (n [%])

   

0.91

   Transfer to another acute care facility

5 (14.3%)

9 (14.3%)

14 (14.3%)

 

   Transfer to a chronic care facility

4 (11.4%)

8 (12.7%)

12 (12.2%)

 

   Home

22 (62.9%)

33 (52.4%)

55 (56.1%)

 

   Expired

2 (5.7%)

6 (9.5%)

8 (8.2%)

 

   Missing

2 (5.7%)

7 (11.1%)

9 (9.2%)

 

Mortality status at 7 months: dead (n [%])

2 (5.7%)

11 (17.5%)

13 (13.3%)

0.13

  1. APC, activated protein C; ICU, intensive care unit; IQR, interquartile range; LOS, length of stay.